TTR and Hepatic fibrosis: Taken together, these findings suggest that CTS might play a contributory role in the progression of liver fibrosis by augmenting the biosynthesis of cholesterol (Figure 3) that, in turn, activates HSCs, redox, oxidant stress, inflammatory, and, HIF-1α pathways during chronic liver disease.